MVV Energie AG (LON:0FCK)

Inozyme Pharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	1,720	1,722	1,772	1,670	1,810	1,556
Market Cap Growth	-5.88%	-2.82%	6.09%	-7.74%	16.35%	0.50%
Enterprise Value	3,171	2,808	2,812	2,752	3,056	3,082
PE Ratio	13.34	11.31	1.96	-	10.61	18.25
PS Ratio	0.35	0.33	0.31	0.32	0.50	0.50
PB Ratio	0.79	0.82	0.82	0.78	1.20	1.12
P/FCF Ratio	21.75	24.10	-	2.88	2.30	18.57
P/OCF Ratio	3.75	4.16	-	1.99	1.75	4.48
EV/Sales Ratio	0.62	0.53	0.48	0.52	0.84	0.98
EV/EBITDA Ratio	6.15	6.05	2.81	16.69	5.26	9.16
EV/EBIT Ratio	9.48	9.06	3.37	-	7.26	18.57
EV/FCF Ratio	40.09	39.30	-	4.74	3.88	36.78
Debt / Equity Ratio	0.69	0.68	0.73	0.78	1.07	1.12
Debt / EBITDA Ratio	3.06	2.96	1.54	9.36	2.72	4.43
Debt / FCF Ratio	19.00	19.86	-	2.91	2.05	18.60
Quick Ratio	0.79	0.48	0.41	0.17	0.19	0.66
Current Ratio	1.32	1.20	1.18	1.06	1.02	1.12
Asset Turnover	0.69	0.73	0.40	0.31	0.43	0.70
Return on Equity (ROE)	10.21%	10.00%	30.59%	0.51%	20.96%	7.44%
Return on Assets (ROA)	2.77%	2.67%	3.55%	-0.02%	3.09%	2.32%
Return on Capital (ROIC)	5.54%	5.48%	13.92%	-0.09%	8.89%	3.52%
Return on Capital Employed (ROCE)	7.80%	7.70%	19.10%	-	9.60%	4.90%
Earnings Yield	7.50%	8.84%	51.15%	-15.39%	9.43%	5.48%
Earnings Yield	7.50%	8.84%	51.15%	-15.39%	9.43%	5.48%
FCF Yield	4.60%	4.15%	-45.74%	34.77%	43.55%	5.39%
Dividend Yield	3.45%	4.28%	4.66%	3.62%	4.97%	4.50%
Payout Ratio	53.70%	52.22%	6.62%	-	31.50%	63.17%
Total Shareholder Return	3.48%	4.28%	4.66%	3.62%	4.97%	4.50%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.